Related Experiment Video
Updated: Aug 17, 2025

11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.7K
Key performance indicators of breast cancer screening programmes in Italy, 2011-2019
Francesca Battisti1, Paola Mantellini1, Patrizia Falini1
1SC Screening e Prevenzione Secondaria, Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy.
Annali Dell'Istituto Superiore Di Sanita
|December 13, 2022
Summary
Italian breast cancer screening programs saw increased coverage from 2011-2019, but a rising recall rate and falling positive predictive value indicate a need for improved resource allocation and training.
Area of Science:
- Public Health
- Oncology
- Epidemiology
Background:
- Evaluation of performance indicators for organized breast cancer screening programs in Italy between 2011 and 2019.
- Focus on key metrics to assess the effectiveness and efficiency of national screening initiatives.
Purpose of the Study:
- To analyze trends in breast cancer screening performance indicators across Italy.
- To identify regional variations and areas for improvement in screening programs.
Main Methods:
- Utilized aggregated data from over 150 Italian regional/sub-regional screening programs.
- Estimated invitation and examination coverage, participation rate (PR), recall rate (RR), detection rate, and positive predictive value (PPV).
- Analyzed data by age group, geographical macro-area, and region.
Main Results:
- Observed a positive increasing trend in coverage, particularly in Southern regions.
- Participation rate (PR) remained stable nationwide.
- Noted an increasing recall rate (RR) and a decreasing positive predictive value (PPV), especially during initial screenings and in specific regions.
Conclusions:
- Increased screening coverage in Italy is associated with a decline in certain performance indicators, necessitating better resource allocation and staff training.
- Continuous monitoring of breast cancer screening programs is crucial for maintaining and improving effectiveness.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413
Prevalence and Incidence
707
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
707

